Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Guille is two years and eight months old. He lives with Desanto Shinawi Syndrome (DESSH), a rare pathology diagnosed in only about 100 people around the world
About Zolgensma: Rs 17-crore single-dose injection needed by Karnataka boy battling rare genetic disease tribuneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneindia.com Daily Mail and Mail on Sunday newspapers.
New Delhi: A staggering Rs 17 crore for a single jab! That’s the cost of one Zolgensma injection used for children under two suffering from spinal muscular atrophy.